These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quantitation of two forms of pulmonary cytochrome P-450 in microsomes, using substrate specificities. Franklin MR; Wolf CR; Serabjit-Singh C; Philpot RM Mol Pharmacol; 1980 May; 17(3):415-20. PubMed ID: 7393217 [No Abstract] [Full Text] [Related]
4. Pulmonary cytochromes P-450 from rabbits treated with 3-methylcholanthrene. Ueng TH; Alvares AP Mol Pharmacol; 1982 Jul; 22(1):221-8. PubMed ID: 7121450 [No Abstract] [Full Text] [Related]
6. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice. Dekant W; Assmann M; Urban G Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 enzyme activities in the Australian brushtail possum trichosurus vulpesula: a comparison with the rat, rabbit, sheep and chicken. Olkowski A; Gooneratne R; Eason C Vet Hum Toxicol; 1998 Apr; 40(2):70-6. PubMed ID: 9554057 [TBL] [Abstract][Full Text] [Related]
8. Components of the cytochrome P450-dependent monooxygenase system and 'NADPH-independent benzo[a]pyrene hydroxylase' activity in a wide range of marine invertebrate species. Solé M; Livingstone DR Comp Biochem Physiol C Toxicol Pharmacol; 2005 May; 141(1):20-31. PubMed ID: 15979946 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of renal and liver microsomal cytochrome P-450 system in two animal models. Yoshimura R; Yoshimura N; Nakatani T; Ohyama A; Miyao Y; Yamamoto K; Kishimoto T Transplant Proc; 1994 Oct; 26(5):2915. PubMed ID: 7940921 [No Abstract] [Full Text] [Related]
10. Renal tumorigenicity of 1,1-dichloroethene in mice: the role of male-specific expression of cytochrome P450 2E1 in the renal bioactivation of 1,1-dichloroethene. Speerschneider P; Dekant W Toxicol Appl Pharmacol; 1995 Jan; 130(1):48-56. PubMed ID: 7839370 [TBL] [Abstract][Full Text] [Related]
11. [Structure-activity characteristics of cytochrome P-450c21. Immunochemical approaches and limited proteolysis]. Guzov VM; Zel'ko IN; Bylinskaia SA; Usanov SA Biokhimiia; 1994 Aug; 59(8):1149-63. PubMed ID: 7819402 [TBL] [Abstract][Full Text] [Related]
12. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5. Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180 [TBL] [Abstract][Full Text] [Related]
13. [Heterologous expression of functionally active human cytochrome P-450s. Cytochrome P-450IIIA4 catalyzes the biotransformation of the anabolic steroid hormone methandrostenolone]. Krynetskiĭ EIu; Kovaleva IE; Luzikov VN Biokhimiia; 1994 Feb; 59(2):282-7. PubMed ID: 8155788 [TBL] [Abstract][Full Text] [Related]
14. Membrane topology of N-terminal residues of cytochromes P-450 2B4 and 1A2. Shumyantseva VV; Kuznetsova GP; Uvarov VYu ; Archakov AI Biochem Mol Biol Int; 1994 Aug; 34(1):183-90. PubMed ID: 7849620 [TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies. Berson A; Wolf C; Chachaty C; Fisch C; Fau D; Eugene D; Loeper J; Gauthier JC; Beaune P; Pompon D J Pharmacol Exp Ther; 1993 Apr; 265(1):366-72. PubMed ID: 8386241 [TBL] [Abstract][Full Text] [Related]
16. Cytochrome P-450-dependent bioactivation of 1,1-dichloroethylene to a reactive epoxide in human lung and liver microsomes. Dowsley TF; Reid K; Petsikas D; Ulreich JB; Fisher RL; Forkert PG J Pharmacol Exp Ther; 1999 May; 289(2):641-8. PubMed ID: 10215634 [TBL] [Abstract][Full Text] [Related]
17. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299 [TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody. Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Lampen A; Christians U; Guengerich FP; Watkins PB; Kolars JC; Bader A; Gonschior AK; Dralle H; Hackbarth I; Sewing KF Drug Metab Dispos; 1995 Dec; 23(12):1315-24. PubMed ID: 8689938 [TBL] [Abstract][Full Text] [Related]
20. HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. Roe AL; Snawder JE; Benson RW; Roberts DW; Casciano DA Biochem Biophys Res Commun; 1993 Jan; 190(1):15-9. PubMed ID: 8380689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]